Best Medical Stocks To Own Right Now

Schwab Charles Investment Management Inc. raised its stake in shares of Globus Medical Inc (NYSE:GMED) by 8.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 421,775 shares of the medical device company’s stock after purchasing an additional 31,253 shares during the period. Schwab Charles Investment Management Inc. owned 0.44% of Globus Medical worth $21,013,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of GMED. Victory Capital Management Inc. increased its position in Globus Medical by 13,908.8% during the first quarter. Victory Capital Management Inc. now owns 1,113,982 shares of the medical device company’s stock worth $55,499,000 after purchasing an additional 1,106,030 shares during the last quarter. NWQ Investment Management Company LLC grew its stake in Globus Medical by 43.1% during the fourth quarter. NWQ Investment Management Company LLC now owns 1,245,219 shares of the medical device company’s stock worth $51,179,000 after buying an additional 375,234 shares during the period. Redmile Group LLC purchased a new stake in Globus Medical during the fourth quarter worth approximately $8,573,000. Guggenheim Capital LLC grew its stake in Globus Medical by 1,283.8% during the fourth quarter. Guggenheim Capital LLC now owns 223,176 shares of the medical device company’s stock worth $9,173,000 after buying an additional 207,048 shares during the period. Finally, Cookson Peirce & Co. Inc. purchased a new stake in Globus Medical during the first quarter worth approximately $9,322,000. 62.82% of the stock is owned by hedge funds and other institutional investors.

Best Medical Stocks To Own Right Now: Warren Resources Inc.(WRES)

Advisors’ Opinion:

  • [By Shane Hupp]

    Northland Securities restated their corporate rating on shares of W Resources (LON:WRES) in a research note issued to investors on Wednesday.

    Shares of LON WRES opened at GBX 0.43 ($0.01) on Wednesday. W Resources has a 52 week low of GBX 0.25 ($0.00) and a 52 week high of GBX 0.72 ($0.01).

Best Medical Stocks To Own Right Now: U.S. Bancorp(USB)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Cumberland Partners Ltd bought a new stake in U.S. Bancorp (NYSE:USB) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 11,400 shares of the financial services provider’s stock, valued at approximately $570,000.

  • [By Motley Fool Staff]

    U.S. Bancorp (NYSE:USB) has long been one of the most efficient big banks in the United States. But the Minneapolis-based bank doesn’t approach efficiency in the same way that most of its competitors do. As opposed to focusing on expenses, U.S. Bancorp has minimized its efficiency ratio by driving revenue.

  • [By Stephan Byrd]

    U.S. Bancorp (NYSE:USB) – Equities research analysts at Jefferies Financial Group upped their Q2 2018 earnings per share estimates for U.S. Bancorp in a report issued on Monday, July 9th. Jefferies Financial Group analyst K. Usdin now forecasts that the financial services provider will earn $1.02 per share for the quarter, up from their prior estimate of $1.00. Jefferies Financial Group also issued estimates for U.S. Bancorp’s Q3 2018 earnings at $1.05 EPS, Q4 2018 earnings at $1.03 EPS, FY2018 earnings at $4.06 EPS and FY2019 earnings at $4.35 EPS.

  • [By Matthew Frankel]

    After the results of the capital plan reviews were announced, most banks individually announced increases (or maintenance) of their stock buybacks and dividends for the next year. Here are a few of the most significant:

    Bank of America (NYSE:BAC) will give shareholders a 25% dividend increase to an annualized rate of $0.60 per share and will also increase its buyback authorization to $20.6 billion over the next year, up from the previous year’s $12.9 billion. Citigroup (NYSE:C) is giving shareholders an impressive 41% dividend hike to a quarterly payout of $0.45 per share and is also planning to spend up to $17.6 billion on buybacks over the year, a modest but significant $2 billion increase over the previous plan. Wells Fargo (NYSE:WFC) was one of the big positive surprises, after a tough couple of years for the bank. Wells announced that its dividend will increase to $0.43 per share in the third quarter, and that it plans to spend as much as $24.5 billion on buybacks over the next year — a sharp increase from the past year’s $11.5 billion. JPMorgan Chase (NYSE:JPM) is raising its dividend by 43% to $0.80 per quarter, and is planning to buy back as much as $20.7 billion in shares over the next year, a mild increase from its 2017 capital plan, which called for $19.4 billion in buybacks. U.S. Bancorp (NYSE:USB) plans to increase its dividend by 23% to a quarterly payout of $0.37 and to repurchase as much as $3 billion of its stock over the next year, up from the previous authorization of $2.6 billion. American Express’ (NYSE:AXP) capital plan was closely watched, since the bank had decided to suspend buybacks for the first half of 2018 in order to bolster capital levels. The bank announced that it would repurchase up to $3.4 billion in shares over the next year and also plans to raise its quarterly dividend from $0.35 to $0.39 per share.

    And as I mentioned earlier, Goldman Sachs and Morgan Stanley were both instructed to leave their previous capi

  • [By Joseph Griffin]

    GW Henssler & Associates Ltd. grew its position in shares of U.S. Bancorp (NYSE:USB) by 2.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 263,877 shares of the financial services provider’s stock after purchasing an additional 6,667 shares during the quarter. GW Henssler & Associates Ltd.’s holdings in U.S. Bancorp were worth $13,199,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on U.S. Bancorp (USB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks To Own Right Now: Plug Power Inc.(PLUG)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Plug Power Inc. (NASDAQ: PLUG) was started with an Outperform rating and assigned a $2.50 price target at Oppenheimer on Thursday. This call represented 28% in implied upside from the prior $1.95 closing price, but its shares were at $1.98 late on Friday. Plug Power has a small following with a consensus analyst target of $3.54, and this call was targeting fuel cell systems for the material handling and stationary power markets. Plug Power’s 52-week range is $1.53 to $3.21.

  • [By Paul Ausick]

    Plug Power Inc. (NASDAQ: PLUG) saw short interest rise by 3.1% to 37.61 million shares. Days to cover rose from eight to 12. In the two weeks to June 15, the share price rose by nearly 3%. The stock’s 52-week range is $1.53 to $3.21, and shares closed most recently at $2.03, up about 4.6% for the day.

  • [By Ethan Ryder]

    Plug Power Inc (NASDAQ:PLUG) was down 2.1% during trading on Friday following a dissappointing earnings announcement. The company traded as low as $1.89 and last traded at $1.88. Approximately 139,031 shares were traded during mid-day trading, a decline of 94% from the average daily volume of 2,159,332 shares. The stock had previously closed at $1.92.

  • [By Paul Ausick]

    Plug Power Inc. (NASDAQ: PLUG) saw short interest rise by 6.2% to 36.55 million shares. Days to cover fell from 10 to seven, and about 16.2% of the company’s shares were short. In the two weeks to May 15, the share price soared about 16.6%. The stock’s 52-week range is $1.53 to $3.21, and shares closed Thursday at $2.15, up about 0.5% for the day.

  • [By Scott Levine]

    The deal with Weichai Power, moreover, is noteworthy in that it distinguishes Ballard from its fuel-cell peer, Plug Power (NASDAQ:PLUG). Although the material handling equipment market has been its bread and butter, Plug Power has made inroads in broadening its reach into the electric-vehicle market in the U.S., and management is keen on expanding its footprint in China. On the company’s recent Q2 earnings call, however, management noted that it has failed to find a worthy partner. It seems, therefore, that in the race to the Chinese electric-vehicle market, Ballard has taken the pole position.  

  • [By Paul Ausick]

    Plug Power Inc. (NASDAQ: PLUG) saw short interest dip by 7.5% to 34.81 million shares. Days to cover remained unchanged at 12, and about 16.5% of the company’s shares were short. In the final two weeks of June, the share price rose by 2.5%. The stock’s 52-week range is $1.53 to $3.21, and shares closed Wednesday at $2.06, flat for the day.

Best Medical Stocks To Own Right Now: Endologix, Inc.(ELGX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Endologix (NASDAQ:ELGX) was upgraded by investment analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued on Wednesday.

  • [By Ethan Ryder]

    These are some of the media stories that may have impacted Accern’s scoring:

    Get Endologix alerts:

    $30.85 Million in Sales Expected for Endologix, Inc. (ELGX) This Quarter (americanbankingnews.com) Zacks: Analysts Expect Endologix, Inc. (ELGX) Will Announce Earnings of -$0.25 Per Share (americanbankingnews.com) Don’t Sleep On Vienna: Stocks To Watch Now Are Tyson Foods, Inc. (TSN), Endologix, Inc. (ELGX) (gvtimes.com) current gravitate: Kohl’s Corporation, (NYSE: KSS), Endologix, Inc., (NASDAQ: ELGX) (nysetradingnews.com) Review of Financial analysis: General Electric Company (NYSE:GE), Endologix, Inc. (NASDAQ:ELGX), QEP Resources … (thestreetpoint.com)

    Shares of NASDAQ:ELGX traded down $0.22 during midday trading on Monday, hitting $1.98. The stock had a trading volume of 1,591,600 shares, compared to its average volume of 642,128. The stock has a market capitalization of $186.36 million, a PE ratio of -4.13 and a beta of 0.03. The company has a current ratio of 1.90, a quick ratio of 1.20 and a debt-to-equity ratio of 5.37. Endologix has a fifty-two week low of $1.86 and a fifty-two week high of $6.72.

  • [By Max Byerly]

    Endologix (NASDAQ:ELGX)‘s stock had its “hold” rating restated by investment analysts at Oppenheimer in a report issued on Wednesday.

Best Medical Stocks To Own Right Now: Vanguard Information Technology ETF (VGT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Dubuque Bank & Trust Co. trimmed its stake in shares of Vanguard Information Technology ETF (NYSEARCA:VGT) by 4.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,740 shares of the exchange traded fund’s stock after selling 1,045 shares during the quarter. Dubuque Bank & Trust Co.’s holdings in Vanguard Information Technology ETF were worth $3,718,000 at the end of the most recent quarter.

  • [By Jim Crumly]

    Technology was the only sector in the green, with the Vanguard Information Technology ETF (NYSEMKT:VGT) rising 0.3%. The price of gold and other metals fell, and the VanEck Vectors Gold Miners ETF (NYSEMKT:GDX) dropped 3.2%. 

  • [By Dan Caplinger]

    So far, most markets are up in 2018, and that’s lifted many ETFs in the Vanguard family. But a few funds have seen extraordinary performance. Among the best so far this year are Vanguard Information Technology (NYSEMKT:VGT), Vanguard Small-Cap Growth (NYSEMKT:VBK), and Vanguard Consumer Discretionary (NYSEMKT:VCR), and below, we’ll take a closer look at how they’ve achieved their dominance in 2018.

  • [By Jim Crumly]

    The results of the election in Brazil lifted emerging market stocks, especially the iShares MSCI Brazil ETF (NYSEMKT:EWZ), which rose 6.7%. Technology stocks were laggards; the Vanguard Information Technology ETF (NYSEMKT:VGT) fell 1.3%. 

Best Medical Stocks To Own Right Now: DoubleLine Opportunistic Credit Fund(DBL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Doubleline Opportunistic Credit Fund common stock (NYSE:DBL) announced a monthly dividend on Friday, June 1st, Zacks reports. Investors of record on Thursday, June 14th will be paid a dividend of 0.167 per share by the investment management company on Friday, June 29th. This represents a $2.00 dividend on an annualized basis and a yield of 9.41%. The ex-dividend date is Wednesday, June 13th.

  • [By Max Byerly]

    News headlines about Doubleline Opportunistic Credit Fund common stock (NYSE:DBL) have been trending somewhat positive on Monday, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Doubleline Opportunistic Credit Fund common stock earned a news impact score of 0.04 on Accern’s scale. Accern also gave media stories about the investment management company an impact score of 47.2090833571026 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Joseph Griffin]

    Doubleline Opportunistic Credit Fund (NYSE:DBL) declared a monthly dividend on Monday, October 1st, NASDAQ reports. Stockholders of record on Thursday, October 11th will be paid a dividend of 0.167 per share by the investment management company on Wednesday, October 31st. This represents a $2.00 annualized dividend and a dividend yield of 9.98%. The ex-dividend date of this dividend is Wednesday, October 10th.

Leave a Reply

Your email address will not be published. Required fields are marked *